Skip to content

How A Digital Health Solution Is Helping To Save Women's Lives In Kenya

How A Digital Health Solution Is Helping To Save Women's Lives In Kenya

How A Digital Health Solution Is Helping To Save Women’s Lives In Kenya

How A Digital Health Solution Is Helping To Save Women's Lives In Kenya

We are thrilled to share the exciting news that Pascal Koenig, our esteemed Chair of the Board of Directors, has been featured in Forbes for his role as a co-founder of Malaica, a digital health startup making a significant impact in Kenya! 

 

The Forbes article titled “How A Digital Health Solution Is Helping To Save Women’s Lives In Kenya” highlights the groundbreaking work being done by Malaica to address the alarming maternal mortality rates in the region. Pascal, together with Dr. Lorraine Muluka and other visionary entrepreneurs, founded Malaica with a shared mission to improve women’s health outcomes.

 

Malaica’s innovative solution connects pregnant women with personal midwives who provide continuous guidance and support throughout their pregnancy journey. Through regular WhatsApp chats and video calls, these dedicated midwives offer valuable information, address concerns, and ensure the women receive appropriate medical care, even if they lack health insurance.

 

The impact of Malaica’s intervention is already evident, as showcased by a success story featured in the article. A woman experiencing symptoms of preeclampsia, thanks to the trust she had in her assigned midwife, sought timely care at a recommended clinic. Prompt intervention saved both her and the baby, highlighting the vital role Malaica plays in identifying urgent cases and ensuring timely access to necessary care.

 

Furthermore, Malaica leverages technology to provide regular pregnancy-related information through WhatsApp, empowering women with knowledge about their changing bodies and the stages of pregnancy.

 

With approximately 200 pregnant women currently benefiting from Malaica’s program, the startup has ambitious plans for expansion. Through their next investment round, they aim to reach 20,000 women, ensuring even greater impact in the lives of expectant mothers. Malaica intends to utilize AI techniques, such as ChatGPT, to provide personalized answers to common pregnancy-related questions, allowing midwives to focus on more complex cases and provide efficient support.

 

We are incredibly proud of Pascal Koenig’s involvement in Malaica and the transformative work being done to save women’s lives in Kenya. This recognition in Forbes underscores the importance of their mission and the positive impact they are making in the field of digital health. Read below:

 

https://www.forbes.com/sites/lisafalco/2023/05/12/how-a-digital-health-solution-is-saving-womens-lives-in-kenya/  

 

#DigitalHealth #MaternalHealthcare #Malaica #ForbesFeature #HealthTech #Innovation #WomenEmpowerment

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Inside Scailyte - Episode 10: Meet Dennis Göhlsdorf

In our latest episode of "Inside Scailyte," we're excited to introduce you to Dennis Göhlsdorf, our...

Read more

Recent News

Precision Med TRI-CON 2024

Join us for our presentation on "Enabling Precision Medicine by Combining Single-Cell Multi-Omics Da...

Read more

Recent News

Inside Scailyte - Episode 9: Meet Shaoline Sheppard

In the latest episode of "Inside Scailyte," we're thrilled to introduce you to Shaoline Sheppard, ou...

Read more

Recent News

NextGen Omics US 2024

Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our...

Read more

Recent News

AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL

In our latest white paper, "AI-driven single-cell data analysis identifies a cell signature predicti...

Read more

Recent News

Inside Scailyte - Episode 8: Meet Sajid Maqbool

Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of "In...

Read more

Recent News

Inside Scailyte – Episode 7: Meet Anna Dimitrova

Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of "Inside Sc...

Read more

Recent News

ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale

ScaiPod's mission is clear: develop next-generation clinical biomarkers for precise immuno-oncology ...

Read more

Recent News

01 /04

Inside Scailyte - Episode 10: Meet Dennis Göhlsdorf

In our latest episode of "Inside Scailyte," we're excited to introduce you to Dennis Göhlsdorf, our...

Read more

Precision Med TRI-CON 2024

Join us for our presentation on "Enabling Precision Medicine by Combining Single-Cell Multi-Omics Da...

Read more

Recent News

02 /04

Inside Scailyte - Episode 9: Meet Shaoline Sheppard

In the latest episode of "Inside Scailyte," we're thrilled to introduce you to Shaoline Sheppard, ou...

Read more

NextGen Omics US 2024

Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our...

Read more

Recent News

03 /04

AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL

In our latest white paper, "AI-driven single-cell data analysis identifies a cell signature predicti...

Read more

Inside Scailyte - Episode 8: Meet Sajid Maqbool

Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of "In...

Read more

Recent News

04 /04

Inside Scailyte – Episode 7: Meet Anna Dimitrova

Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of "Inside Sc...

Read more

ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale

ScaiPod's mission is clear: develop next-generation clinical biomarkers for precise immuno-oncology ...

Read more

Recent News